Phase II Clinical Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft

Sponsor
Bolton Medical (Industry)
Overall Status
Approved for marketing
CT.gov ID
NCT01327742
Collaborator
(none)
15

Study Details

Study Description

Brief Summary

This study is a continuation of the pivotal trial studying the safety and efficacy of the Relay thoracic stent-graft system to treat thoracic aortic aneurysms. Efficacy is being evaluated by the device-related adverse event rate of endovascular repair (via the Relay thoracic stent-graft) through 1 year. Safety is being evaluated by comparing major adverse events through 1 year in subjects treated with the Relay thoracic stent-graft to those who underwent surgical repair.

Condition or Disease Intervention/Treatment Phase
  • Device: Relay Thoracic Stent-Graft

Study Design

Study Type:
Expanded Access
Official Title:
Phase II Clinical Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft in Patients With Thoracic Aortic Pathologies

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • Subjects with diagnosed descending thoracic aneurysm or penetrating ulcer

    • Subjects whose anatomy can accommodate the Relay device

    • Subjects who consent to participate

    • Subjects who agree to a follow-up schedule

    Exclusion Criteria:
    • Subjects with lesions other than thoracic aneurysm and penetrating ulcer

    • Subjects with less than 1 year life expectancy

    • Subjects who are pregnant

    • Subjects with medical conditions that wold complicate the endovascular procedure or confound results (e.g., Marfan's syndrome, morbid obesity, severe coronary artery disease)

    • Subjects participating in another investigational study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Arizona Heart Hospital Phoenix Arizona United States 85006
    2 Washington Hospital Center Washington District of Columbia United States 20010
    3 University of Florida Gainesville Florida United States 32610
    4 Baptist Cardiac and Vascular Institute Miami Florida United States 33176
    5 Indiana Heart Hospital Indianapolis Indiana United States 46250
    6 Massachusetts General Hospital Boston Massachusetts United States 02114
    7 University of Michigan Ann Arbor Michigan United States 48109
    8 University of North Carolina Chapel Hill North Carolina United States 27599
    9 East Carolina University Greenville North Carolina United States 27834
    10 Cleveland Clinic Foundation Cleveland Ohio United States 44195
    11 Ohio State University Columbus Ohio United States 43210
    12 University of Pennsylvania Philadelphia Pennsylvania United States 19104
    13 University of Pittsburgh Pittsburgh Pennsylvania United States 15213
    14 Sentara Heart Hospital Norfolk Virginia United States 23510
    15 University Washington Seattle Washington United States 98105

    Sponsors and Collaborators

    • Bolton Medical

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Bolton Medical
    ClinicalTrials.gov Identifier:
    NCT01327742
    Other Study ID Numbers:
    • IP-0004-06 rev I
    First Posted:
    Apr 4, 2011
    Last Update Posted:
    Nov 19, 2012
    Last Verified:
    Nov 1, 2012
    Keywords provided by Bolton Medical
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 19, 2012